Cargando…
Purified Inactivated Zika Vaccine Candidates Afford Protection against Lethal Challenge in Mice
In response to the 2016 global public health emergency of international concern announced by the World Health Organization surrounding Zika virus (ZIKV) outbreaks, we developed a purified inactivated Zika virus vaccine (PIZV) candidate from ZIKV strain PRVABC59, isolated during the outbreak in 2015....
Autores principales: | Baldwin, Whitney R., Livengood, Jill A., Giebler, Holli A., Stovall, Janae L., Boroughs, Karen L., Sonnberg, Stephanie, Bohning, Kelly J., Dietrich, Elizabeth A., Ong, Yee Tsuey, Danh, Hoang K., Patel, Hetal K., Huang, Claire Y.-H., Dean, Hansi J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220238/ https://www.ncbi.nlm.nih.gov/pubmed/30405178 http://dx.doi.org/10.1038/s41598-018-34735-7 |
Ejemplares similares
-
Single dose of chimeric dengue-2/Zika vaccine candidate protects mice and non-human primates against Zika virus
por: Baldwin, Whitney R., et al.
Publicado: (2021) -
Complete Protection in Macaques Conferred by Purified Inactivated Zika Vaccine: Defining a Correlate of Protection
por: Young, Ginger, et al.
Publicado: (2020) -
A high throughput reporter virus particle microneutralization assay for quantitation of Zika virus neutralizing antibodies in multiple species
por: Bohning, Kelly, et al.
Publicado: (2021) -
Persistence of Immunogenicity of a Purified Inactivated Zika Virus Vaccine Candidate in Healthy Adults: 2 Years of Follow-up Compared With Natural Infection
por: Acosta, Camilo J, et al.
Publicado: (2022) -
Genetic and Phenotypic Characterization of Manufacturing Seeds for a Tetravalent Dengue Vaccine (DENVax)
por: Huang, Claire Y.-H., et al.
Publicado: (2013)